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Background: Ultraviolet B (UVB) induces multiple in-
flammatory and carcinogenic reactions. In skin, UVB induces 
to secrete several kinds of inflammatory cytokines from ker-
atinocytes and also increases angiogenic process via the 
modulation of vascular endothelial growth factor (VEGF) 
production. Interleukin-21 (IL-21) is an inflammatory cyto-
kine and produced by activated T cells. The biologic functions 
of IL-21 have not yet extensively studied. Methods: In the 
present study, we investigate the production of IL-21 from 
human keratinocyte cell line, HaCaT and its biological effect 
after exposure to UVB. Results: First, we confirmed the IL-21 
production and its receptor expression in HaCaT. And then, 
the change of IL-21 and VEGF production in HaCaT by UVB 
irradiation was examined. Not only IL-21 but also VEGF pro-
duction was enhanced by UVB irradiation. Next, to de-
termine relationship of enhanced production of IL-21 and 
VEGF, we detected VEGF production after neutralization of 
IL-21. VEGF production was reduced by IL-21 neutralization, 
which indicates that the IL-21 is involved in the VEGF 
production. Conclusion: Taken together, our results suggest 
that IL-21 and VEGF production is enhanced by UVB irradi-
ation in HaCaT. In addition, it seems that IL-21 plays a role in 




Interleukin (IL)-21 is a member of the type I cytokine family 
with significant sequence homology to IL-2, IL-4, and, in par-
ticular, IL-15 (1-3). IL-21 is also the most recently described 
member of the common γ-chain cytokine family, and found 
to  be  a  potent  immunomodulatory  cytokine  (4).  IL-21  re-
ceptor (IL-21R) has been reported to associate with the com-
mon γ chain, a property it shares with the receptors for IL-2, 
IL-4, IL-7, IL-9, and IL-15. The intracellular signaling pathway 
of IL-21R involves Janus kinase 1 (Jak1), Jak3, signal trans-
ducer and activator of transcription 1 (Stat1), Stat3, Stat5a and 
stat 5b (5-7). IL-21 was first noted to be produced by acti-
vated CD4＋ T cells, whereas expression of its receptor was 
somewhat broader (8,9). IL-21 serves a critical role for im-
munoglobulin production and terminal B cell differentiation, 
acts as a T cell comitogen and can drive the expansion of 
CD8＋ T cells, can negatively regulate dendritic cell function 
and plays an essential role in the differentiation of Th17 cells 
(10).  Also,  IL-21  is  implicated  in  the  pathogenesis  of  auto-
immunity (11,12) and exhibits potent actions as an antitumor 
agent  (13).
    The process of new blood vessel formation or angiogenesis 
is essential for tumor growth and wound healing as it is crit-
ical for supply of oxygen and nutrients. Especially, vascular 
endothelial  growth  factor  (VEGF)  has  an  essential  role  in 
angiogenesis. VEGF is thought to play an important role in 
the  increased  vascular  permeability  and  angiogenesis  asso-
ciated  with  tumor  malignancies.  It  augments  neovasculari-
zation and tumor growth in cells transfected with the VEGF 
gene versus control cells (14). Overexpression of VEGF and 
both of its receptors has been documented in a number of 
animal and human tumors (15). VEGF is also overexpressed The Production IL-21 and VEGF in UVB-irradiated Human Keratinocyte Cell Line, HaCaT
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by  epidermal  keratinocytes  in  certain  non-neoplastic  proc-
esses of the skin which are characterized by increased micro-
vascular  permeability  and  angiogenesis,  e.g.  cutaneous 
wound  healing  (16)  and  psoriasis  (17).  Recently,  up-regu-
lation of VEGF was also found in bullous pemphigoid, eryth-
ema multiforme, and dermatitis herpetiformis (18), which are 
all  associated with hyperpermeable dermal  microvessels.  In 
addition, members of the type I cytokine family such as IL-2 
and IL-4, which is analogy to IL-21, are suggested to affect 
the  formation  of  new  blood  vessels  (19-21).
    Ultraviolet B (UVB) induces multiple inflammatory and car-
cinogenic reactions like angiogenesis. In skin or human kera-
tinocyte cells, UVB induces to secrete inflammatory cytokines 
such as IL-1α, IL-6 and IL-8 (22,23). In addition, cutaneous 
angiogenesis is enhanced by exposure to UVB irradiation (24) 
and UVB-induced skin angiogenesis is mediated by upregulat-
ing of VEGF (25). In present study, we examined the pro-
duction and regulation of IL-21 and VEGF by UVB irradiation 
in  a  human  keratinocyte  cell  line,  HaCaT.
MATERIALS AND METHODS
Cells and UVB irradiation
The human keratinocyte cell line, HaCaT was obtained from 
American Type Culture Collection (Manassas, VA, USA). Cells 
were cultured in RPMI 1640 supplemented with 2 mM L-gluta-
mine,  100  units/ml  penicillin,  100μg/ml  streptomycin,  and 
10% heat-inactivated fetal bovine serum. This cell line in the 
log phase of growth was used for experiments. Cells were 
exposed  to  UVB  irradiation  (290∼320  nm)  using  bank  of 
lamps (Waldmann, Schwenningen, Germany). The irradiance 
of the lamps was measured with a photometer (Waldmann, 
Schwenningen,  Germany).
RT-PCR
Total RNA was isolated from 5×10
6 cultured cells using easy 
BLUETM, and cDNA was made using Power cDNA synthesis 
kit. Then, cDNA was amplified with IL-21 primers (5'-GAG 
ATC CAG TCC TGG CAA-3', 5'-GCA AGT TAG ATC CTC AGG 
AA-3'; product=480 bp). Cycling conditions for IL-21 were 1 
min at 95
oC, 1 min at 56
oC, and 1 min at 72
oC for 40 cycles. 
PCR products  were  separated on  1.2%  agarose  gel,  stained 
with  ethidium  bromide  and  visualized  under  UV  light.
Flow cytometry
Surface flow cytometry was used to detect the expression of 
IL-21 receptor (IL-21R). HaCaT cells were collected, washed 
twice with 0.15 M phosphate-buffered saline (PBS), and in-
cubated with anti-human IL-21R monoclonal antibody (R&D 
system,  Minneapolis,  MN,  USA).  And  then  cells  were  in-
cubated  with  FITC-conjugated  anti-mouse  IgG  (Sigma,  St. 
Louis,  MO,  USA),  and  analyzed  with  flow  cytometer. 
Intracellular flow cytometry was performed to detect the pro-
duction of IL-21. HaCaT cells were collected after UVB irradi-
ation, washed twice with 0.15 M PBS. After fixing with fix-
ation buffer (2% paraformaldehyde in PBS) for 20 min on ice, 
cells were permeablized with permeabilization buffer (0.1% 
saponinin PBS) for 30 min on ice. Then, cells incubated with 
FITC-conjugated  anti-goat  IgG  (Sigma,  St.  Louis,  MO,  USA) 
for 30 min on ice, washed twice with permeabilization buffer, 
and analyzed with flow cytometer. Flow cytometric data was 
obtained using an Epics ALTRA (Beckman coulter, Brea, CA, 
USA)  after  processed  by  the  Expo32  program  (Beckman 
coulter,  Brea,  CA,  USA).
ELISA
Culture supernatants of HaCaT cells were collected after UVB 
irradiation.  The  VEGF  concentration  in  the  culture  super-
natants was measured by ELISA (R&D). VEGF ELISA was per-
formed  according  to  the  manufacturer's  instructions.
RESULTS
Expression of IL-21 and its receptors on the surface 
of HaCaT cells
It is reported that the interaction between keratinocytes and 
inflammatory  cells  are  one  of  the  important  factors  on  the 
pathogenesis of Psoriasis, chronic inflammatory disease of the 
skin (26). In addition, IL-21 receptor is expressed on a variety 
of immune cells as well as non-immune cells (27). Therefore, 
we investigated the expression of IL-21 and its receptor on 
human  keratinocyte  cell  line,  HaCaT  by  flow  cytometry 
analysis. As shown in Fig. 1, we found the spontaneous IL-21 
production  and  IL-21R  expression  in  HaCaT. 
The enhancement of IL-21 production from HaCaT 
by UVB irradiation
There are several reports regarding the pivotal role of IL-21 
in chronic inflammatory diseases, including rheumatoid arthri-
tis, inflammatory bowel disease, and psoriasis. Therefore we 
investigated  whether  IL-21  is  produced  in  skin  under  in-
flammatory condition by UVB, which can lead inflammatory The Production IL-21 and VEGF in UVB-irradiated Human Keratinocyte Cell Line, HaCaT
Hyemin Kim, et al.
77 IMMUNE NETWORK http://www.ksimm.or.kr Volume 10 Number 2 April 2010
Figure 2. IL-21 production from HaCaT cells by UVB irradiation. (A) 
HaCaT cells (7×10
6) were exposed to 0, 100, 150, 200, 300 J/m
2
of UVB and incubated for 6 hrs. After, total RNA was isolated and 
cDNA was synthesized, RT-PCR for IL-21 was performed. β-actin was
used as a loading control. (B) HaCaT cells (3×10
6) were exposed to 
150 J/m
2 of UVB and incubated for overnight. After cells were 
harvested, IL-21 production was measured by intracellular flow 
cytometry.
Figure 1. IL-21 production and its receptor expression in human 
keratinocyte cell line, HaCaT. (A) HaCaT cells (1×10
6) were 
harvested, intracellular IL-21 was measured by flow cytometry as 
described in Materials and Methods. (B) HaCaT cells (1×10
6) were
harvested, the surface expression of IL-21 receptor was examined by 
flow cytometry as described in Materials and Methods.
Figure 3. VEGF production from human keratinocyte cell line, HaCaT
by UVB. HaCaT cells (3×10
6) were exposed to 50, 100 J/m
2 of UVB
and incubated for overnight. Then, culture supernatants were 
collected, and VEGF concentration was measured by ELISA.
responses and production of various inflammatory cytokines 
and chemokines (28). To determine the optimal dose of UVB, 
the changes of IL-21 mRNA expression were examined after 
cells were exposure to various ranges of U VB from 100 to 
300 J/m
2. IL-21 mRNA expression was increased in a dose-de-
pendent manner of UVB. Since IL-21 mRNA expression was 
peaked under 150 J/m
2 of UVB, we investigated IL-21 pro-
duction  at  proteins  level  by  intracellular  flow  cytometry 
analysis. As shown in Fig. 2B, IL-21 production was increased 
by  UVB  irradiation.
The secretion of VEGF was enhance by UVB in HaCaT 
cells
Angiogenic process is an essential step for the regulation of 
inflammatory  responses.  We  already  reported  IL-18  pro-
duction is up-regulated from HaCaT by UVB irradiation. In 
addition, IL-18 is a reported as one of the angiogenic factors. 
Therefore, we investigated whether VEGF expression is regu-
lated by UVB irradiation. As we expected, VEGF production 
is increased by UVB irradiation in a dose-dependent manner 
(Fig.  3).The Production IL-21 and VEGF in UVB-irradiated Human Keratinocyte Cell Line, HaCaT
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Figure 4. Inhibition of UVB-induced VEGF production by the 
treatment of soluble IL-21 receptor. HaCaT cells (3×10
6) were 
pre-treated with sIL-21R for 2 hrs before exposure to 100 J/m
2 of UVB.
After UVB irradiation, cells were incubated for overnight. And then, 
culture supernatants were collected, and the concentration of VEGF 
was measured by ELISA.
IL-21 production was involved in the VEFG produc-
tion
As we have already shown that IL-21 production and its re-
ceptor expression and VEGF production is increased by UVB 
irradiation, we further investigated the relationship between 
IL-21 and VEGF production by UVB irradiation. When the au-
tocrine effect of IL-21 on UVB-irradiated HaCaT was blocked 
b y s ol ub le  I L- 21  re c ep to r,  w e  fo un d  co m ple t e i nh ib it io n  of 
UVB-  induced  VEGF  production  (Fig.  4).
DISCUSSION
In the present study, we investigated the production of IL-21 
and VEGF in a human keratinocyte cell line, HaCaT by UVB 
irradiation.  And  IL-21  is  involved  in  the  secretion  of  VEGF 
by UVB exposure. Interleukin (IL)-21 is a pleotropic cytokine 
with  immune-regulatory  properties  and  immune-therapeutic 
capacity. A recent study demonstrated that IL-21 receptor is 
present on normal and tumor endothelial cells and can medi-
ate angiostatic properties (21). Although several inflammatory 
cytokines such as TNF-α, IL-6 and IL-8 are secreted by UVB 
(28), there was no report of the production of IL-21 by UVB 
irradiation. However, we showed the exposure of UVB to hu-
man kerationocyte cell line, HaCaT induced significant pro-
duction of IL-21 and increased the surface expression of IL-21 
receptors. Nurieva et al. represented that IL-21 acts as an au-
tocrine  cytokine  and  was  involved  in  the  generation  of  in-
flammatory T cells (29). Thus, increased expression of both 
intracellular  IL-21  and  its  surface  receptors  by  exposure  to 
UVB on HaCaT cells (Fig. 1 and 2) is suspected to expand 
the  activity  of  IL-21.
    Vascular  endothelial  growth  factor  (VEGF)  stimulates  the 
growth of new blood vessels, so it  is involved  in not only 
tumor growth and metastasis but also wound healing. VEGF 
elicits  a  strong  angiogenic  response  in  a  variety  of  in  vivo 
models. VEGF participates in the angiogenic responses by in-
creasing  microvascular  permeability.  Also,  VEGF  stimulate 
several  endothelial  cell  responses  in  cell  culture  including 
proliferation, migration, survival, and secretion of matrix-de-
grading enzymes (14). Acute ultraviolet B (UVB) irradiation 
of the skin results in erythema, vasodilation, edema, and an-
giogenesis, which is associated with the expression of VEGF 
by  epidermal  keratinocytes  (30).  Sublethal  and  physiologi-
cally relevant doses of UVB increased VEGF mRNA and pro-
t e i n  l e v e l s  u p o n  i r r a d i a t i o n  o f  q u i e s c e n t  k e r a t i n o c y t e s .  T h e  
UVB-induced  overexpression  of  VEGF  is  dependent  on  de 
novo protein synthesis and occurs via release of soluble me-
diators, which subsequently turn on VEGF expression (31). 
It is unclear whether VEGF is required for the damage or re-
p a i r  p r o c e s s  t h a t  o c c u r s  i n  t h e  s k i n  o n  U V B  e x p o s u r e .  
However, a study with VEGF-overexpressing transgenic mice 
reported that VEGF promotes the cutaneous damage that oc-
curs after UVB exposure and the author mentioned VEGF sig-
naling  pathway  might  serve  as  a  novel  target  for  the  pre-
vention of UVB-induced photodamage (30). Our result also 
indicated the elevated secretion of VEGF by UVB irradiation, 
but the effect of produced VEGF is considered to be further 
studied. 
  W e  a l s o  s h o w e d  t h a t  t h e  t r e a t m e n t  o f  s o l u b l e  I L - 2 1 R  
blocked the production of VEGF by UVB irradiation. It means 
that VEGF production is modulate by IL-21 and that IL-21 can 
f un c ti on  in  si mi lar  to  V EG F .  Th e r ep or t t h at  co - lo ca liz at io n 
of IL-21R and VEGF was consistently seen in the skin of pa-
tients  with  skin  sclerosis  (27)  is  supporting  our  results. 
Recently,  it  is  also  reported  that  IL-21  receptor  regulates 
wound healing and fibrosis by controlling Th2-mediated in-
flammation  (32).
    In conclusion, a human keratinocyte cell line, HaCaT ex-
pressed both IL-21 and IL-21 receptor, and the irradiation of 
UVB induced the increase of the IL-21 production. Also, the 
secretion of VEGF is elevated by exposure to UVB, and IL-21 
was involved in the VEGF production. It suggests that IL-21 
exhibits the angiogenetic activity by modulating VEGF when 
UVB  is  exposed  to  skin  keratinocytes.The Production IL-21 and VEGF in UVB-irradiated Human Keratinocyte Cell Line, HaCaT
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